Haplotype-dependent HLA susceptibility to nasopharyngeal carcinoma in a Southern Chinese population

Genes and Immunity

Volumn 11, Issue 4, 2010, Pages 334-342

  Tang, M ^a,b   Zeng, Y ^c   Poisson, A ^a   Marti, D ^a   Guan, L ^a   Zheng, Y ^b   Deng, H ^b   Liao, J ^d   Guo, X ^a,c   Sun, S ^e   Nelson, G ^a   De The G ^f   Winkler, C A ^a   O'Brien, S J ^a   Carrington, M ^a   Gao, X X ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Wuzhou Red Cross Hospital   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d Cangwu Institute for Nasopharyngeal Carcinoma Control and Prevention   (China)

^e PEKING UNIVERSITY   (China)

^f INSTITUT PASTEUR   (France)

Author keywords

Haplotype; HLA; Nasopharyngeal carcinoma; Stratified analysis

Indexed keywords

HLA A ANTIGEN; HLA A2 ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CASE CONTROL STUDY; CHINA; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; POPULATION RESEARCH; PRIORITY JOURNAL; SOUTH ASIA; SOUTHEAST ASIA;

ALLELES; CASE-CONTROL STUDIES; CHINA; COHORT STUDIES; HAPLOTYPES; HLA ANTIGENS; HUMANS; INCIDENCE; NASOPHARYNGEAL NEOPLASMS;

EID: 77953122093     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2009.109     Document Type: Article

References (29)

1. Brown TM, Heath CW, Lang RM, Lee SK, Whalley BW. Nasopharyngeal cancer in Bermuda. Cancer 1976; 37: 1464-1468.
2. Yu MC, Garabrant DH, Huang TB, Henderson BE. Occupational and other non-dietary risk factors for nasopharyngeal carcinoma in Guangzhou, China. Int J Cancer 1990; 45: 1033-1039.
3. Guo X, Johnson RC, Deng H, Liao J, Guan L, Nelson GW et al. Evaluation of non-viral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China. Int J Cancer 2009; 124: 2942-2947.
4. Coffin CM, Rich SS, Dehner LP. Familial aggregation of nasopharyngeal carcinoma and other malignancies. A clin-icopathologic description. Cancer 1991; 68: 1323-1328.
5. Jeannel D, Hubert A, de Vathaire F, Ellouz R, Camoun M, Ben Salem M et al. Diet, living conditions and nasopharyngeal carcinoma in Tunisia-a case-control study. Int J Cancer 1990; 46: 421-425.
6. Laramore GE, Clubb B, Quick C, Amer MH, Ali M, Greer W et al. Nasopharyngeal carcinoma in Saudi Arabia: a retrospective study of 166 cases treated with curative intent. Int J Radiat Oncol Biol Phys 1988; 15: 1119-1127.
7. Johansen LV, Mestre M, Overgaard J. Carcinoma of the nasopharynx: analysis of treatment results in 167 consecutively admitted patients. Head Neck 1992; 14: 200-207.
8. Lee AW, Foo W, Mang O, Sze WM, Chappell R, Lau WH et al. Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980-1999): an encouraging reduction in both incidence and mortality. Int J Cancer 2003; 103: 680-685.
9. Lu SJ, Day NE, Degos L, Lepage V, Wang PC, Chan SH et al. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature 1990; 346: 470-471.
10. Guo XC, Scott K, Liu Y, Dean M, David V, Nelson GW et al. Genetic factors leading to chronic Epstein-Barr virus infection and nasopharyngeal carcinoma in South East China: study design, methods and feasibility. Hum Genomics 2006; 2: 365-375.
11. Burt RD, Vaughan TL, McKnight B, Davis S, Beckmann AM, Smith AG et al. Associations between human leukocyte antigen type and nasopharyngeal carcinoma in Caucasians in the United States. Cancer Epidemiol Biomarkers Prev 1996; 5: 879-887.
12. Simons MJ, Wee GB, Chan SH, Shanmugaratnam K, Day NE, de-The G. Immunogenetic aspects of nasopharyngeal carcinoma (NPC) III. HLA type as a genetic marker of NPC predisposition to test the hypothesis that Epstein-Barr virus is an etiological factor in NPC. IARC Sci Publ 1975: 249-258.
13. Hu SP, Day NE, Li DR, Luben RN, Cai KL, Ou-Yang T et al. Further evidence for an HLA-related recessive mutation in nasopharyngeal carcinoma among the Chinese. Br J Cancer 2005; 92: 967-970.
14. Hildesheim A, Apple RJ, Chen CJ, Wang SS, Cheng YJ, Klitz W et al. Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 2002; 94: 1780-1789.
15. Chan SH, Day NE, Kunaratnam N, Chia KB, Simons MJ. HLA and nasopharyngeal carcinoma in Chinese\a further study. Int J Cancer 1983; 32: 171-176.
16. Henle G, Henle W. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer 1976; 17: 1-7.
17. Zeng Y, Zhang LG, Li HY, Jan MG, Zhang Q, Wu YC et al. Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China. Int J Cancer 1982; 29: 139-141.
18. Zeng Y, Zhang LG, Wu YC, Huang YS, Huang NQ, Li JYet al. Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou City, China. Int J Cancer 1985; 36: 545-547.
19. Wu SB, Hwang SJ, Chang AS, Hsieh T, Hsu MM, Hsieh RP et al. Human leukocyte antigen (HLA) frequency among patients with nasopharyngeal carcinoma in Taiwan. Anticancer Res 1989; 9: 1649-1653.
20. Kwok WW, Schwarz D, Nepom BS, Hock RA, Thurtle PS, Nepom GT. HLA-DQ molecules form alpha-beta heterodimers of mixed allotype. J Immunol 1988; 141: 3123-3127.
21. Lu CC, Chen JC, Tsai ST, Jin YT, Tsai JC, Chan SH et al. Nasopharyngeal carcinoma-susceptibility locus is localized to a 132 kb segment containing HLA-A using high-resolution microsatellite mapping. Int J Cancer 2005; 115: 742-746.
22. Ooi EE, Ren EC, Chan SH. Association between microsatellites within the human MHC and nasopharyngeal carcinoma. Int J Cancer 1997; 74: 229-232.
23. Beyrer C, Artenstein AW, Rugpao S, Stephens H, VanCott TC, Robb ML et al. Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group. J Infect Dis 1999; 179: 59-67.
24. Fukada K, Tomiyama H, Chujoh Y, Miwa K, Kaneko Y, Oka S et al. HLA-A*1101-restricted cytotoxic T lymphocyte recognition for a novel epitope derived from the HIV-1 Env protein. Aids 1999; 13: 2597-2599.
25. Yu MC, Huang TB, Henderson BE. Diet and nasopharyngeal carcinoma: a case-control study in Guangzhou, China. Int J Cancer 1989; 43: 1077-1082.
26. Gao X, Bashirova A, Iversen AK, Phair J, Goedert JJ, Buchbinder S et al. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med 2005; 11: 1290-1292.
27. Bao MZ, Wang JX, Dorman JS, Trucco M. HLA-DQ beta non-ASP-57 allele and incidence of diabetes in China and the USA. Lancet 1989; 2: 497-498.
28. Cevenini R, Donati M, Rumpianesi F, Moroni A, Paolucci P. An immunoperoxidase assay for the detection of specific IgA antibody in Epstein-Barr virus infections. J Clin Pathol 1984; 37: 440-443.
29. Gao X, Nelson GW, Karacki P, Martin MP, Phair J, Kaslow R et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 2001; 344: 1668-1675.